Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations

Ingrid K. Svenson, Mark T. Kloos, P. Craig Gaskell, Martha A. Nance, James Y. Garbern, Shin Ichi Hisanaga, Margaret A Pericak-Vance, Allison E. Ashley-Koch, Douglas A. Marchuk

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Hereditary spastic paraplegia (HSP) is a genetically heterogeneous neurodegenerative disease characterized by wide variability in phenotypic expression, both within and among families. The most-common cause of autosomal dominant HSP is mutation of the gene encoding spastin, a protein of uncertain function. We report the existence of intragenic polymorphisms of spastin that modify the HSP phenotype. One (S44L) is a previously described recessively acting allele and the second is a novel allele affecting the adjacent amino acid residue (P45Q). In 4 HSP families in which either L44 or Q45 segregates independently of a missense or splicing mutation in the AAA domain of spastin, L44 and Q45 are each associated with a striking decrease in age at onset in the presence of the AAA domain mutations. Using a bioinformatics approach, we found that the highly conserved S44 is predicted to be phosphorylated by a number of family members of the proline-directed serine/threonine cyclin-dependent kinases (Cdks). Cdk1 and Cdk5 showed no kinase activity toward synthetic spastin peptide in an in vitro kinase assay, suggesting that this serine residue may be phosphorylated by a different Cdk. Our identification of S44L and P45Q as modifiers of the HSP phenotype suggests a role for spastin phosphorylation by Cdks in the neurodegeneration of the most-common form of HSP.

Original languageEnglish
Pages (from-to)157-164
Number of pages8
JournalNeurogenetics
Volume5
Issue number3
DOIs
StatePublished - Sep 1 2004
Externally publishedYes

Fingerprint

Hereditary Spastic Paraplegia
Mutation
Genes
Cyclin-Dependent Kinases
Phosphotransferases
Alleles
Phenotype
Protein-Serine-Threonine Kinases
Computational Biology
Age of Onset
Proline
Neurodegenerative Diseases
Serine
Phosphorylation
Amino Acids
Peptides

Keywords

  • Cyclin-dependent kinases
  • Hereditary spastic paraplegia
  • Spastin

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)

Cite this

Svenson, I. K., Kloos, M. T., Gaskell, P. C., Nance, M. A., Garbern, J. Y., Hisanaga, S. I., ... Marchuk, D. A. (2004). Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics, 5(3), 157-164. https://doi.org/10.1007/s10048-004-0186-z

Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. / Svenson, Ingrid K.; Kloos, Mark T.; Gaskell, P. Craig; Nance, Martha A.; Garbern, James Y.; Hisanaga, Shin Ichi; Pericak-Vance, Margaret A; Ashley-Koch, Allison E.; Marchuk, Douglas A.

In: Neurogenetics, Vol. 5, No. 3, 01.09.2004, p. 157-164.

Research output: Contribution to journalArticle

Svenson, IK, Kloos, MT, Gaskell, PC, Nance, MA, Garbern, JY, Hisanaga, SI, Pericak-Vance, MA, Ashley-Koch, AE & Marchuk, DA 2004, 'Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations', Neurogenetics, vol. 5, no. 3, pp. 157-164. https://doi.org/10.1007/s10048-004-0186-z
Svenson IK, Kloos MT, Gaskell PC, Nance MA, Garbern JY, Hisanaga SI et al. Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics. 2004 Sep 1;5(3):157-164. https://doi.org/10.1007/s10048-004-0186-z
Svenson, Ingrid K. ; Kloos, Mark T. ; Gaskell, P. Craig ; Nance, Martha A. ; Garbern, James Y. ; Hisanaga, Shin Ichi ; Pericak-Vance, Margaret A ; Ashley-Koch, Allison E. ; Marchuk, Douglas A. / Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. In: Neurogenetics. 2004 ; Vol. 5, No. 3. pp. 157-164.
@article{2166eccaed404c70bfd645071ab010d6,
title = "Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations",
abstract = "Hereditary spastic paraplegia (HSP) is a genetically heterogeneous neurodegenerative disease characterized by wide variability in phenotypic expression, both within and among families. The most-common cause of autosomal dominant HSP is mutation of the gene encoding spastin, a protein of uncertain function. We report the existence of intragenic polymorphisms of spastin that modify the HSP phenotype. One (S44L) is a previously described recessively acting allele and the second is a novel allele affecting the adjacent amino acid residue (P45Q). In 4 HSP families in which either L44 or Q45 segregates independently of a missense or splicing mutation in the AAA domain of spastin, L44 and Q45 are each associated with a striking decrease in age at onset in the presence of the AAA domain mutations. Using a bioinformatics approach, we found that the highly conserved S44 is predicted to be phosphorylated by a number of family members of the proline-directed serine/threonine cyclin-dependent kinases (Cdks). Cdk1 and Cdk5 showed no kinase activity toward synthetic spastin peptide in an in vitro kinase assay, suggesting that this serine residue may be phosphorylated by a different Cdk. Our identification of S44L and P45Q as modifiers of the HSP phenotype suggests a role for spastin phosphorylation by Cdks in the neurodegeneration of the most-common form of HSP.",
keywords = "Cyclin-dependent kinases, Hereditary spastic paraplegia, Spastin",
author = "Svenson, {Ingrid K.} and Kloos, {Mark T.} and Gaskell, {P. Craig} and Nance, {Martha A.} and Garbern, {James Y.} and Hisanaga, {Shin Ichi} and Pericak-Vance, {Margaret A} and Ashley-Koch, {Allison E.} and Marchuk, {Douglas A.}",
year = "2004",
month = "9",
day = "1",
doi = "10.1007/s10048-004-0186-z",
language = "English",
volume = "5",
pages = "157--164",
journal = "Neurogenetics",
issn = "1364-6745",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations

AU - Svenson, Ingrid K.

AU - Kloos, Mark T.

AU - Gaskell, P. Craig

AU - Nance, Martha A.

AU - Garbern, James Y.

AU - Hisanaga, Shin Ichi

AU - Pericak-Vance, Margaret A

AU - Ashley-Koch, Allison E.

AU - Marchuk, Douglas A.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Hereditary spastic paraplegia (HSP) is a genetically heterogeneous neurodegenerative disease characterized by wide variability in phenotypic expression, both within and among families. The most-common cause of autosomal dominant HSP is mutation of the gene encoding spastin, a protein of uncertain function. We report the existence of intragenic polymorphisms of spastin that modify the HSP phenotype. One (S44L) is a previously described recessively acting allele and the second is a novel allele affecting the adjacent amino acid residue (P45Q). In 4 HSP families in which either L44 or Q45 segregates independently of a missense or splicing mutation in the AAA domain of spastin, L44 and Q45 are each associated with a striking decrease in age at onset in the presence of the AAA domain mutations. Using a bioinformatics approach, we found that the highly conserved S44 is predicted to be phosphorylated by a number of family members of the proline-directed serine/threonine cyclin-dependent kinases (Cdks). Cdk1 and Cdk5 showed no kinase activity toward synthetic spastin peptide in an in vitro kinase assay, suggesting that this serine residue may be phosphorylated by a different Cdk. Our identification of S44L and P45Q as modifiers of the HSP phenotype suggests a role for spastin phosphorylation by Cdks in the neurodegeneration of the most-common form of HSP.

AB - Hereditary spastic paraplegia (HSP) is a genetically heterogeneous neurodegenerative disease characterized by wide variability in phenotypic expression, both within and among families. The most-common cause of autosomal dominant HSP is mutation of the gene encoding spastin, a protein of uncertain function. We report the existence of intragenic polymorphisms of spastin that modify the HSP phenotype. One (S44L) is a previously described recessively acting allele and the second is a novel allele affecting the adjacent amino acid residue (P45Q). In 4 HSP families in which either L44 or Q45 segregates independently of a missense or splicing mutation in the AAA domain of spastin, L44 and Q45 are each associated with a striking decrease in age at onset in the presence of the AAA domain mutations. Using a bioinformatics approach, we found that the highly conserved S44 is predicted to be phosphorylated by a number of family members of the proline-directed serine/threonine cyclin-dependent kinases (Cdks). Cdk1 and Cdk5 showed no kinase activity toward synthetic spastin peptide in an in vitro kinase assay, suggesting that this serine residue may be phosphorylated by a different Cdk. Our identification of S44L and P45Q as modifiers of the HSP phenotype suggests a role for spastin phosphorylation by Cdks in the neurodegeneration of the most-common form of HSP.

KW - Cyclin-dependent kinases

KW - Hereditary spastic paraplegia

KW - Spastin

UR - http://www.scopus.com/inward/record.url?scp=5444231843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5444231843&partnerID=8YFLogxK

U2 - 10.1007/s10048-004-0186-z

DO - 10.1007/s10048-004-0186-z

M3 - Article

C2 - 15248095

AN - SCOPUS:5444231843

VL - 5

SP - 157

EP - 164

JO - Neurogenetics

JF - Neurogenetics

SN - 1364-6745

IS - 3

ER -